DNA ligases as therapeutic targets

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• DNA ligases are essential enzymes that join DNA fragments during replication and repair.
• Human cells express three DNA ligase genes (LIG1, LIG3, LIG4) with conserved catalytic regions involved in DNA nick sealing.
• LIG3 is unique, producing multiple protein isoforms, including one vital for mitochondrial genome maintenance.

Purpose of the Study:

• To elucidate the structural and functional roles of human DNA ligases in DNA transactions.
• To investigate the unique features of LIG3 and its isoforms.
• To explore the therapeutic potential of small molecule DNA ligase inhibitors in cancer treatment.

Main Methods:

• Biophysical studies to determine the structure of DNA ligase catalytic regions.
• Analysis of protein-protein interactions in DNA transactions.
• Structure-based drug design to identify small molecule inhibitors.
• Preclinical studies using human cancer cell lines and mouse models.

Main Results:

• DNA ligase catalytic regions adopt a compact, ring structure around DNA nicks.
• Protein-protein interactions guide DNA ligases to specific DNA repair and replication sites.
• Small molecule DNA ligase inhibitors demonstrate cytotoxicity and potentiate DNA damaging agents.
• Preclinical data suggest potential anti-cancer applications for DNA ligase inhibitors.

Conclusions:

• Human DNA ligases possess distinct yet overlapping functions in nuclear DNA replication and repair.
• LIG3 plays a critical role in both nuclear and mitochondrial DNA maintenance.
• DNA ligase inhibitors represent a promising new class of anti-cancer therapeutics.